John Seibyl
Active 1991–2025
- 121
- Papers
- 25,691
- Citations
- 84
- h-index
- 117
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine62.9%
- Neuroscience22.2%
- Biochemistry, Genetics and Molecular Biology5.5%
- Psychology4.5%
- Computer Science2.3%
- Health Professions0.4%
- Other2.2%
Topics
- Parkinson's Disease Mechanisms and Treatments10.7%
- Neurological disorders and treatments7%
- Alzheimer's disease research and treatments6.8%
- Dementia and Cognitive Impairment Research5.6%
- Neurotransmitter Receptor Influence on Behavior4.2%
- Functional Brain Connectivity Studies3.4%
- Other62.3%
Coauthors
- Kenneth Marek54
- Robert B. Innis33
- Danna Jennings28
- Ronald M. Baldwin23
- Andrew Siderowf20
- Christopher S. Coffey19
- Henryk Barthel19
- Sami S. Zoghbi19
- Dennis S. Charney18
- Gilles Tamagnan17
- Karl Kieburtz17
- Lana M. Chahine17
- Olivier Barret17
- Caroline M. Tanner16
- Brit Mollenhauer15
- Tanya Simuni15
- Andrew Stephens14
- Christopher H. van Dyck14
- Daniel Weintraub14
- Marc Laruelle14
- Robert T. Malison14
- Osama Sabri13
- Tatiana Foroud13
- Andrew Singleton12
All papers
- The Parkinson Progression Marker Initiative (PPMI)
Authors: Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline M. Tanner, Tanya Simuni, Christopher S. Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire C. Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur W. Toga, Karen Crawford, Alison B. Ansbach, Pasquale De Blasio, Michele Piovella, John Q. Trojanowski, Les Shaw, Andrew Singleton, Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 cited by 1,915
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Authors: Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnović, Seung Ho Choi, Ryan Kurth, Chelsea Caspell‐Garcia, Christopher S. Coffey, Mark Frasier, Luís M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto - The Lancet Neurology 2023 cited by 693
- A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Authors: Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, Michael C. Brumm, Teresa Buracchio, Michelle Campbell, Sohini Chowdhury, Christopher S. Coffey, Luis Concha‐Marambio, Tien Dam, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Caroline Gochanour, Danna Jennings, Karl Kieburtz, Catherine Kopil, Kalpana Merchant, Brit Mollenhauer, Thomas J. Montine, Kelly Nudelman, Gennaro Pagano, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Caroline M. Tanner, Eduardo Tolosa, Daniel Weintraub, Yuge Xiao, Andrew Siderowf, Billy Dunn, Kenneth Marek - The Lancet Neurology 2024 cited by 563
- CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Authors: Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q. Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla, Katharina Buck, Katharina Zink, Christina Rabe, Kaj Blennow, Leslie M. Shaw, for the Swedish BioFINDER study group, Alzheimer's Disease Neuroimaging Initiative - Alzheimer s & Dementia 2018 cited by 829
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Authors: Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Tanya Simuni, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, the Parkinson's Progression Markers Initiative - Annals of Clinical and Translational Neurology 2018 cited by 686
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Authors: Osama Sabri, Marwan N. Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao, Thomas G. Beach, Christopher C. Rowe, James B. Leverenz, Bernardino Ghetti, James W. Ironside, Ana M. Catafau, Andrew Stephens, André Mueller, Norman Koglin, Anja Hoffmann, Katrin Roth, Cornelia Reininger, Walter Schulz‐Schaeffer, Florbetaben Phase 3 Study Group - Alzheimer s & Dementia 2015 cited by 609
- Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Authors: Matthias Brendel, Henryk Barthel, Thilo van Eimeren, Kenneth Marek, Leonie Beyer, Mengmeng Song, Carla Palleis, Mona Gehmeyr, Urban M. Fietzek, Gesine Respondek, Julia Sauerbeck, Alexander Nitschmann, Christian Zach, Jochen Hammes, Michael T. Barbe, Oezguer A. Onur, Frank Jessen, Dorothee Saur, Matthias L. Schroeter, Jost‐Julian Rumpf, Michael Rullmann, Andreas Schildan, Marianne Patt, Bernd Neumaier, Olivier Barret, Jennifer Madonia, David Russell, Andrew Stephens, Sigrun Roeber, Jochen Herms, Kai Bötzel, Joseph Claßen, Peter Bartenstein, Victor L. Villemagne, Johannes Levin, Günter U. Höglinger, Alexander Drzezga, John Seibyl, Osama Sabri - JAMA Neurology 2020 cited by 253
- Tau deposition patterns are associated with functional connectivity in primary tauopathies
Authors: Nicolai Franzmeier, Matthias Brendel, Leonie Beyer, Luna Slemann, Gábor G. Kovács, Thomas Arzberger, Carolin Kurz, Gesine Respondek, Milica Ječmenica‐Lukić, Davina Biel, Anna Rubinski, Lukas Frontzkowski, Selina Hummel, André Müller, Anika Finze, Carla Palleis, Emanuel Joseph, Endy Weidinger, Sabrina Katzdobler, Mengmeng Song, Gloria Biechele, Maike Kern, Maximilian Scheifele, Boris‐Stephan Rauchmann, Robert Perneczky, Michael Rullman, Marianne Patt, Andreas Schildan, Henryk Barthel, Osama Sabri, Jost J. Rumpf, Matthias L. Schroeter, Joseph Claßen, Victor L. Villemagne, John Seibyl, Andrew Stephens, Edward B. Lee, David G. Coughlin, Armin Giese, Murray Grossman, Corey T. McMillan, Ellen Gelpí, Laura Molina‐Porcel, Yaroslau Compta, John C. van Swieten, Laura Donker Laat, Claire Troakes, Safa Al‐Sarraj, John Robinson, Sharon X. Xie, David J. Irwin, Sigrun Roeber, Jochen Herms, Mikael Simons, Peter Bartenstein, Virginia M. Lee, John Q. Trojanowski, Johannes Levin, Günter U. Höglinger, Michael Ewers - Nature Communications 2022 cited by 108
- Targeting Prodromal Alzheimer Disease With Avagacestat
Authors: Vladimir Coric, Stephen Salloway, Christopher H. van Dyck, Bruno Dubois, Niels Andreasen, Mark Brody, Craig Curtis, Hilkka Soininen, Stephen Thein, Thomas Shiovitz, Gary D. Pilcher, Steven H. Ferris, Susan Colby, W. Kerselaers, Randy Dockens, Holly Soares, Stephen Kaplita, Feng Luo, Chahin Pachaï, Luc Bracoud, Mark Mintun, Joshua D. Grill, Kenneth Marek, John Seibyl, Jesse M. Cedarbaum, Charles F. Albright, Howard Feldman, Robert Berman - JAMA Neurology 2015 cited by 233
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Authors: Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg, Sebastian Schade, Roland G. Gera, Wenting Wang, Feng Gao, Mark Frasier, Lana M. Chahine, Christopher S. Coffey, Andrew Singleton, Tanya Simuni, Daniel Weintraub, John Seibyl, Arthur W. Toga, Caroline M. Tanner, Karl Kieburtz, Kenneth Marek, Andrew Siderowf, Jesse M. Cedarbaum, Samantha J. Hutten, Claudia Trenkwalder, Danielle Graham - Movement Disorders 2020 cited by 201
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Authors: Silvia Morbelli, Giuseppe Esposito, Javier Arbizu, Henryk Barthel, Ronald Boellaard, Nico I. Bohnen, David J. Brooks, Jacques Darcourt, John Dickson, David Douglas, Alexander Drzezga, Jacob G. Dubroff, Özgül Ekmekçioğlu, Valentina Garibotto, Peter Herscovitch, Phillip H. Kuo, Adriaan A. Lammertsma, Sabina Pappatà, Iván Peñuelas, John Seibyl, Franck Semah, Livia Tossici-Bolt, Elsmarieke van de Giessen, Koen Van Laere, Andrea Varrone, Michele Wanner, George Zubal, Ian Law - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 257
- SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
Authors: Satoshi Minoshima, Alexander Drzezga, Henryk Barthel, Nicolaas I. Bohnen, Mehdi Djekidel, David H. Lewis, Chester A. Mathis, Jonathan McConathy, Agneta Nordberg, Osama Sabri, John Seibyl, Margaret Stokes, Koen Van Laere - Journal of Nuclear Medicine 2016 cited by 258
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Authors: Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni, Jianping Jia, Jiri Hardlund, Hans J. Moebius, Peter Bentham, Karin A. Kook, B. Schelter, Damon Wischik, Charles S. Davis, Roger T. Staff, Vesna Vuksanović, Trevor Ahearn, Luc Bracoud, Kohkan Shamsi, Kenneth Marek, John Seibyl, Gernot Riedel, John M. D. Storey, Charles R. Harrington, Claude M. Wischik - Journal of Alzheimer s Disease 2017 cited by 217
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Authors: Tanya Simuni, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, Sohini Chowdhury, Kenneth Marek, the Parkinson's Progression Marker Initiative* - Movement Disorders 2018 cited by 205
- Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
Authors: André Mueller, Santiago Bullich, Olivier Barret, Jennifer Madonia, Mathias Berndt, Caroline Papin, Audrey Perrotin, Norman Koglin, Heiko Kroth, Andrea Pfeifer, Gilles Tamagnan, John Seibyl, Kenneth Marek, Susan De Santi, Ludger M. Dinkelborg, Andrew Stephens - Journal of Nuclear Medicine 2019 cited by 200
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Authors: Henryk Barthel, Hermann‐Josef Gertz, S. Dresel, Oliver Peters, Peter Bartenstein, Katharina Büerger, Florian Hiemeyer, Sabine Wittemer‐Rump, John Seibyl, Cornelia Reininger, Osama Sabri - The Lancet Neurology 2011 cited by 586
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
Authors: Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Alan Carpenter, Danna Jennings, Carl Sadowsky, Lee P. Adler, Karel D. Kovnat, John Seibyl, Anupa Arora, Krishnendu Saha, Jason Burns, Mark Lowrey, Mark A. Mintun, Daniel Skovronsky, the Florbetapir F 18 Study Investigators - Journal of Nuclear Medicine 2012 cited by 399
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
Authors: Luis Concha‐Marambio, Carly M. Farris, Bret Holguin, Yihua Ma, John Seibyl, Marco J. Russo, Un Jung Kang, Samantha J. Hutten, Kalpana Merchant, Mohammad Shahnawaz, Claudio Soto - Movement Disorders 2021 cited by 66
- MRI-based measurement of hippocampal volume in patients with combat- related posttraumatic stress disorder
Authors: J. Douglas Bremner, Patrick A. Randall, Tammy Scott, Richard A. Bronen, John Seibyl, Steven M. Southwick, Richard Delaney, Gregory McCarthy, Dennis S. Charney, Robert B. Innis - American Journal of Psychiatry 1995 cited by 1,611
- Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort
Authors: Danna Jennings, Andrew Siderowf, Matthew Stern, John Seibyl, Shirley Eberly, David Oakes, Kenneth Marek, for the PARS Investigators - JAMA Neurology 2017 cited by 198
- Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Authors: Zahi Qamhawi, David Towey, Bina Shah, Gennaro Pagano, John Seibyl, Kenneth Marek, Per Borghammer, David J. Brooks, Nicola Pavese - Brain 2015 cited by 219
- Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
Authors: Marc Laruelle, Anissa Abi‐Dargham, C H van Dyck, Roberto Gil, C. D'Souza, Joseph Erdos, Elinore McCance, William H. Rosenblatt, Christine Fingado, Sami S. Zoghbi, Ronald M. Baldwin, John Seibyl, John H. Krystal, Dennis S. Charney, Robert B. Innis - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 1,294
- Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
Authors: Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Peggy Taylor, Leslie M. Shaw, John Q. Trojanowski, Andy Singleton, Mark Frasier, Kenneth Marek, Douglas Galasko, For the Parkinson's Progression Marker Initiative, Parkinson's Progression Marker Initiative, Kenneth Marek, Danna Jennings, Shirley Lasch, Caroline M. Tanner, Tanya Simuni, Christopher S. Coffey, Karl Kieburtz, Renée Wilson, Werner Poewe, Brit Mollenhauer, Tatiana Foroud, Todd Sherer, Sohini Chowdhury, Mark Frasier, Catherine Kopil, Vanessa Arnedo, Alice Rudolph, Cynthia Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Chelsea Caspell, Liz Uribe, Eric D. Foster, Katherine B. Gloer, Jon Yankey, Arthur W. Toga, Karen Crawford, Paola Casalin, Giulia Malferrari, Brit Mollenhauer, Douglas Galasko, Andrew Singleton, Keith A. Hawkins, David Russell, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Matthew Stern, Lana M. Chahine, James B. Leverenz, Samuel Frank, Irene Richard, Klaus Seppi, Holly A. Shill, Hubert Fernandez, Daniela Berg, Isabel Wurster, Douglas Galasko, Zoltan Mari, David J. Brooks, Nicola Pavese, Paolo Barone, Stuart Isaacson, Alberto J. Espay, Dominic B. Rowe, Melanie Brandabur, James W. Tetrud, Grace Liang, Álex Iranzo, Eduardo Tolosa, Laura Leary, C Riordan, Linda Rees, Alicia Portillo, Art Lenahan, Karen Williams, Stephanie Guthrie, Ashlee Brooke Rawlins, Sherry Harlan, Christine Hunter, Baochan Tran, Abigail Darin, Carly Linder, Marne Baca, Heli Venkov, Cathi-Ann Thomas, Raymond James, Cheryl Deeley, Courtney Bishop, Fabienne Sprenger, Diana Willeke, Sanja Obradov, Jennifer Mule, Nancy Monahan, Katharina Gauss and 98 more - Neurology 2017 cited by 152
- Signs and Artifacts in Amyloid PET
Authors: Tamara F. Lundeen, John Seibyl, Matthew F. Covington, Naghmehossadat Eshghi, Phillip H. Kuo - Radiographics 2018 cited by 89
